Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$3.26
−$0.03 · -0.91%
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Previous close
$3.26
−$0.03 · -0.91%
Regular session · ET · Market data may be delayed.
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Day range
Current $3.26
52-week range
Current $3.26
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
82
Deep Value
Sentiment
72
Bullish
Risk
61
High Risk
Momentum
21
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Day range
Current $3.26
52-week range
Current $3.26
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Cash distributions grouped by calendar year; partial years are marked.
$0.60
2025 complete year+33.3% since 2022
2026 partial: $0.60
$0.45
2,022
$0.45
2,023
$0.60
2,024
$0.60
2,025
$0.60
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Apr 7, 2026 | $0.60Special | Apr 7, 2026 | Apr 23, 2026 |
Dividend | Apr 29, 2025 | $0.60Special | Apr 29, 2025 | May 15, 2025 |
Dividend | Mar 25, 2024 | $0.60Special | Mar 26, 2024 | Apr 11, 2024 |
Dividend | May 15, 2023 | $0.45Special | May 16, 2023 | Jun 1, 2023 |
Dividend | May 16, 2022 | $0.45Special | May 17, 2022 | Jun 2, 2022 |
Ex-dividend Apr 7, 2026
$0.60
Special
Record Apr 7, 2026 · Payment Apr 23, 2026
Ex-dividend Apr 29, 2025
$0.60
Special
Record Apr 29, 2025 · Payment May 15, 2025
Ex-dividend Mar 25, 2024
$0.60
Special
Record Mar 26, 2024 · Payment Apr 11, 2024
Ex-dividend May 15, 2023
$0.45
Special
Record May 16, 2023 · Payment Jun 1, 2023
Ex-dividend May 16, 2022
$0.45
Special
Record May 17, 2022 · Payment Jun 2, 2022
Funds reporting this stock among their holdings, ordered by reported position size.
Avantis U.S. Small Cap Value ETFAVUV4.39M0.01%30.86B USD0.25%$119.13-1.11%
Vanguard Morningstar Total Stock Market ETFVTI3.79M0.00%2.3T USD0.03%$381.03-0.40%
iShares Russell 2000 ETFIWM3.78M0.00%78.56B USD0.19%$277.7-1.29%
Vanguard Extended Market ETFVXF1.55M0.00%95.4B USD0.05%$233.49-1.56%
Dimensional - US Targeted Value ETFDFAT1.47M0.00%30B USD0.33%$67.08-1.29%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1.17M0.00%26.69B USD0.33%$37.79-1.23%
Dimensional - US Small Cap ETFDFAS1.03M0.00%33.66B USD0.31%$77.92-1.38%
U.S. Micro Cap Portfolio ETFDFMC841.74K0.01%7.52B USD0.43%$57.50-1.29%Avantis U.S. Small Cap Value ETFAVUVVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATU.S. Small Cap Value Portfolio ETF Class SharesDFSVDimensional - US Small Cap ETFDFASU.S. Micro Cap Portfolio ETFDFMCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
